{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:03Z","timestamp":1786998303814,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["602102"],"award-info":[{"award-number":["602102"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lo 274\/11-2"],"award-info":[{"award-number":["Lo 274\/11-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yebeh.2015.02.027","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T23:17:04Z","timestamp":1430003824000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models"],"prefix":"10.1016","volume":"49","author":[{"given":"Wolfgang","family":"L\u00f6scher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2015.02.027_bb0005","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0010","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0074-7742(06)81018-4","article-title":"Treatment of convulsive status epilepticus","volume":"81","author":"Treiman","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0015","first-page":"CD003723","article-title":"Anticonvulsant therapy for status epilepticus","volume":"9","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0020","first-page":"29","article-title":"Refractory versus non-refractory status epilepticus: frequency, differentiating clinical features, and outcome","volume":"vol. 7","author":"Neligan","year":"2008"},{"issue":"Suppl. 12","key":"10.1016\/j.yebeh.2015.02.027_bb0025","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1167.2009.02367.x","article-title":"Molecular mechanisms of drug resistance in status epilepticus","volume":"50","author":"L\u00f6scher","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0030","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0035","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl. 9","key":"10.1016\/j.yebeh.2015.02.027_bb0040","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1528-1167.2008.01928.x","article-title":"Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs","volume":"49","author":"Wasterlain","year":"2008","journal-title":"Epilepsia"},{"issue":"Suppl. 12","key":"10.1016\/j.yebeh.2015.02.027_bb0045","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1528-1167.2009.02375.x","article-title":"Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: the receptor trafficking hypothesis revisited","volume":"50","author":"Wasterlain","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0050","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0055","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"L\u00f6scher","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2015.02.027_bb0060","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/epi.12297","article-title":"Issues related to development of antiepileptogenic therapies","volume":"54","author":"Pitk\u00e4nen","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0065","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/BF00230647","article-title":"Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats","volume":"102","author":"Lemos","year":"1995","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0070","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0920-1211(01)00272-8","article-title":"Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy","volume":"46","author":"Glien","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0075","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0920-1211(02)00099-2","article-title":"Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations","volume":"51","author":"Klitgaard","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0080","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.103.057091","article-title":"Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy","volume":"308","author":"Rigoulot","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0085","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.eplepsyres.2006.07.014","article-title":"The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy","volume":"72","author":"Francois","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0090","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0095","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1111\/j.1528-1167.2008.01644.x","article-title":"Erythropoietin reduces epileptogenic processes following status epilepticus","volume":"49","author":"Chu","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0100","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/brain\/awu339","article-title":"Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug","volume":"138","author":"Doeser","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0105","doi-asserted-by":"publisher","first-page":"18284","DOI":"10.3390\/ijms140918284","article-title":"Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions","volume":"14","author":"Reddy","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0110","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.spen.2010.06.002","article-title":"Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus","volume":"17","author":"Rajasekaran","year":"2010","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0115","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0306-4522(03)00168-4","article-title":"Molecular and functional changes in voltage-dependent Na(+) channels following pilocarpine-induced status epilepticus in rat dentate granule cells","volume":"119","author":"Ellerkmann","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0120","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"Remy","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0125","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/j.1471-4159.2008.05508.x","article-title":"Altered phosphorylation and localization of the A-type channel, Kv4.2 in status epilepticus","volume":"106","author":"Lugo","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0130","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0135","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1528-1167.2008.01916.x","article-title":"Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus","volume":"50","author":"Kuteykin-Teplyakov","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0140","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fncel.2013.00237","article-title":"P2X receptors as targets for the treatment of status epilepticus","volume":"7","author":"Henshall","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0145","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for antiepileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0150","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nbd.2014.12.015","article-title":"Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers","volume":"75","author":"Brandt","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0325","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1528-1167.2007.01093.x","article-title":"The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy","volume":"48","author":"L\u00f6scher","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0330","first-page":"72","article-title":"Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models","volume":"17","author":"Bourin","year":"1992","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0335","series-title":"Version 4.1","author":"DrugBank","year":"2015"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0340","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-3565(25)13216-3","article-title":"Kinetic and dynamic components of increased benzodiazepine sensitivity in aging animals","volume":"253","author":"Barnhill","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0345","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1476-5381.1991.tb12230.x","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration","volume":"102","author":"Mandema","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0350","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1124\/dmd.31.5.548","article-title":"Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam","volume":"31","author":"Granvil","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0355","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/WNR.0b013e328338ba18","article-title":"The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice","volume":"21","author":"Markowitz","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0360","first-page":"470P","article-title":"Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings]","volume":"67","author":"Mullen","year":"1979","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0365","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s12272-011-1208-7","article-title":"Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats","volume":"34","author":"Koo","year":"2011","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0370","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000056118","article-title":"Alteration of drug kinetics in rats following exposure to trichloroethylene","volume":"63","author":"Kukongviriyapan","year":"2001","journal-title":"Pharmacology"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0375","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0378-4274(85)90053-0","article-title":"Influence of ozone on pentobarbital pharmacokinetics in mice","volume":"24","author":"Graham","year":"1985","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0380","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jps.2600700326","article-title":"Effect of sulfadimethoxine on thiopental distribution and elimination in rats","volume":"70","author":"Yu","year":"1981","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0385","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/bja\/52.8.743","article-title":"Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent","volume":"52","author":"Adam","year":"1980","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0390","first-page":"187","article-title":"Elimination half-life of propofol in effect-site of mice","volume":"37","author":"Guan","year":"2005","journal-title":"Beijing Da Xue Xue Bao"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0395","first-page":"567","article-title":"Pharmacokinetics of ketamine and xylazine in young and old Sprague\u2013Dawley rats","volume":"52","author":"Veilleux-Lemieux","year":"2013","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0400","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/jpet.105.091199","article-title":"Ketamine produces lasting disruptions in encoding of sensory stimuli","volume":"316","author":"Maxwell","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0405","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000455547","article-title":"Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice","volume":"1","author":"Atlas","year":"1980","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0155","first-page":"223","article-title":"GABA\u2013drug interactions","volume":"31","author":"Olsen","year":"1987","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0160","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-4886(86)90274-8","article-title":"Status epilepticus facilitated by pilocarpine in amygdala-kindled rats","volume":"94","author":"Buterbaugh","year":"1986","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0165","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0014-4886(86)90045-2","article-title":"Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats","volume":"91","author":"Jope","year":"1986","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0170","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0306-4522(87)90171-0","article-title":"The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures","volume":"23","author":"Clifford","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0175","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0014-4886(87)90293-7","article-title":"Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats","volume":"97","author":"Morrisett","year":"1987","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0180","first-page":"335","article-title":"Protective effects of GABAergic drugs and other anticonvulsants in lithium-pilocarpine-induced status epilepticus","volume":"18","author":"George","year":"1996","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0185","first-page":"171","article-title":"Absorption, distribution and excretion of 14C-pilocarpine following oral administration to rats","volume":"54","author":"Omori","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0190","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0098-2997(87)90022-7","article-title":"Current views of the pathobiochemistry of epilepsy","volume":"9","author":"Bradford","year":"1987","journal-title":"Mol Aspects Med"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2015.02.027_bb0195","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1111\/j.1528-1157.1993.tb05905.x","article-title":"Pathophysiological mechanisms of brain damage from status epilepticus","volume":"34","author":"Wasterlain","year":"1993","journal-title":"Epilepsia"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2015.02.027_bb0200","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1528-1167.2007.01300.x","article-title":"Cholinergic dysfunction in temporal lobe epilepsy","volume":"48","author":"Friedman","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0205","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00424-009-0766-8","article-title":"Nicotinic receptor channelopathies and epilepsy","volume":"460","author":"Steinlein","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0210","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0006-8993(84)91433-1","article-title":"Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum","volume":"298","author":"McGeer","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0215","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0892-0362(96)00120-1","article-title":"Domoic acid: neurobehavioral and neurohistological effects of low-dose exposure in adult rats","volume":"18","author":"Sobotka","year":"1996","journal-title":"Neurotoxicol Teratol"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2015.02.027_bb0220","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1528-1167.2005.01017.x","article-title":"Plastic changes and disease-modifying effects of scopolamine in the pilocarpine model of epilepsy in rats","volume":"46","author":"Pereira","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0225","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0014-4886(73)90087-3","article-title":"Effects of atropine, reserpine, 6-hydroxydopamine, and handling on seizure development in the rat","volume":"40","author":"Arnold","year":"1973","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0230","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-4886(87)90171-3","article-title":"Effects of treatment with scopolamine and naloxone, singly and in combination, on amygdala kindling","volume":"96","author":"Cain","year":"1987","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0235","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0014-4886(87)90017-3","article-title":"Antagonism of central but not peripheral cholinergic receptors retards amygdala kindling in rats","volume":"95","author":"Westerberg","year":"1987","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0240","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/syn.10064","article-title":"The cholinergic system modulates kindling and kindling-induced mossy fiber sprouting","volume":"44","author":"Adams","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0250","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0255","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cns.12096","article-title":"Treatment of status epilepticus with ketamine, are we there yet?","volume":"19","author":"Dorandeu","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2015.02.027_bb0245","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1528-1167.2011.03243.x","article-title":"Rational polytherapy in the treatment of acute seizures and status epilepticus","volume":"52","author":"Wasterlain","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0260","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2005.06.013","article-title":"Efficacy of the ketamine\u2013atropine combination in the delayed treatment of soman-induced status epilepticus","volume":"1051","author":"Dorandeu","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0265","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0270","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.eplepsyres.2004.02.002","article-title":"Anticonvulsant effects of levetiracetam and levetiracetam\u2013diazepam combinations in experimental status epilepticus","volume":"58","author":"Mazarati","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0275","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0280","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eplepsyres.2013.08.001","article-title":"Treatment and course of different subtypes of status epilepticus","volume":"107","author":"Rantsch","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0285","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0290","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejpn.2009.02.004","article-title":"Lorazepam versus diazepam\u2013phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial","volume":"14","author":"Sreenath","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0295","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/j.1528-1167.2009.02084.x","article-title":"Commentary: translation of laboratory findings to clinic in the treatment of status epilepticus \u2014 a mission impossible?","volume":"50","author":"Pitk\u00e4nen","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0300","first-page":"831260","article-title":"Early use of the NMDA receptor antagonist ketamine in refractory and superrefractory status epilepticus","volume":"2015","author":"Zeiler","year":"2015","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0305","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11910-014-0452-x","article-title":"Refractory and super-refractory status epilepticus \u2014 an update","volume":"14","author":"Hocker","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0310","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Shorvon","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2015.02.027_bb0315","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0920-1211(92)90055-X","article-title":"Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin","volume":"13","author":"H\u00f6nack","year":"1992","journal-title":"Epilepsy Res"},{"issue":"Suppl. 12","key":"10.1016\/j.yebeh.2015.02.027_bb0320","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1528-1167.2009.02366.x","article-title":"What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate","volume":"50","author":"Perucca","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2015.02.027_bb9000","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jnc.12787","article-title":"Dynamics of hippocampal acetylcholine release during lithium-pilocarpine-induced status epilepticus in rats","volume":"131","author":"Hillert","year":"2014","journal-title":"J Neurochem"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505015000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:02:57Z","timestamp":1748343777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505015000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":82,"alternative-id":["S1525505015000839"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.02.027","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2015.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}